Emphasis on Operating Margin and Customer Count
First written in FY2020. 6 of 18 entries say "Advanced", first in FY2021-Q3. Latest entry: 2026-09-14.
The whole theme swung hardest in 2019: 3 of 15 companies on the "Worse" side.
3 other companies' latest entry also says "Raised".
- FY2025AdvancedAnnual report
「Through these initiatives, the company aims to achieve record-high profit for the third consecutive fiscal year in the fiscal year ending September 2026, with net sales of ¥2,484 million, ordinary profit of ¥662 million, an ordinary profit margin on net sales of 26.7%, net profit of ¥451 million, and a net profit margin on net sales of 18.2%.」
In the current fiscal year, net sales were ¥2,406.943 million, operating profit was ¥549.606 million, ordinary profit was ¥652.002 million, and net profit was ¥448.093 million, resulting in record-high profit for the second consecutive fiscal year. The company set specific performance targets for record-high profit for the third consecutive fiscal year. - FY2025-H1AdvancedAnnual report
「As a result of these initiatives, for the 6-month period ended in the first half, net sales were ¥1,236.842 million, up 12.4% year on year; operating profit was ¥345.147 million, up 32.0%; ordinary profit was ¥410.472 million, up 5.3%; and net profit was ¥277.377 million, up 4.4%, resulting in consecutive increases in net sales and profits.」
Regarding the conventional management indicators it emphasizes, including operating profit and customer numbers, the company stated that net sales, operating profit, ordinary profit, and net profit increased year on year for the 6-month period ended in the first half, resulting in consecutive increases in net sales and profits. - FY2024RaisedAnnual report
「Through new developments in the fourth and fifth installments of the AI and voice series using generative AI, following the AI voice products, the company aims to expand sales of the AI and voice series to more than its medium- to long-term target of 3,000 dental clinics and achieve net sales of more than ¥3.5 billion, ordinary profit of ¥1.0 billion, an ordinary profit margin on net sales of 28.5%, net profit of ¥700 million, and a net profit margin on net sales of 20.0%.」
In addition to its conventional focus on operating margin and customer numbers, the company set more specific and ambitious medium- to long-term targets, including deployment of the AI and voice series at more than 3,000 dental clinics, net sales of ¥3.5 billion, and ordinary profit of ¥1.0 billion. - FY2024-Q2Sluggish sales growth and profits above plan for the 6-month periodAnnual report
「As a result of these initiatives, although sales growth remained sluggish, the stable revenue base from monthly fees for the AI and voice electronic medical record integration system and the AI and voice periodontal disease testing system expanded steadily, and sales of dental DX support software performed extremely well, including software for medical assistance and home-visit care in preparation for expanded use of online eligibility verification systems and software such as “Clinic Assist,” which visualizes progress toward greater use of My Number health insurance cards. As a result, for the 6-month period ended in the second quarter, net sales were ¥1,100.398 million, or 94.0% of plan; operating profit was ¥261.284 million, or 114.4% of plan, an increase of ¥32.999 million; ordinary profit was ¥389.805 million, or 145.0% of plan, an increase of ¥120.965 million; and quarterly net profit was ¥265.659 million, up 141.2% versus plan, an increase of ¥77.471 million.」
The company stated that, for the 6-month period ended in the second quarter, net sales were 94.0% of plan and remained sluggish, while operating profit, ordinary profit, and quarterly net profit exceeded plan. - FY2024-Q1First-Quarter Revenue and Earnings DeclineAnnual report
「As a result of these initiatives, although the results for the 3-month period ended in the first quarter were net sales of ¥470.522 million, down 31.6% year on year; operating profit of ¥55.510 million, down 69.7%; ordinary profit of ¥109.960 million, down 40.8%; and quarterly net profit of ¥74.143 million, down 40.5%,」
While advancing sales activities for AI and voice products, the company reported year-on-year declines in net sales, operating profit, ordinary profit, and quarterly net profit for the 3-month period ended in the first quarter. - FY2023-Q3Nine-Month Revenue and Profit DeclineAnnual report
「As a result of linking these activities to sales of its core products, the dental electronic medical record integration system “Hi Dental Spirit XR-10i,” AI-Voice, and P-Voice, net sales for the 9-month period ended in the third quarter were ¥1,614.042 million, down 4.4% year on year; ordinary profit was ¥371.009 million, down 2.6%; and quarterly net profit was ¥251.083 million, down 1.3%.」
While advancing sales activities for products including AI-Voice and P-Voice, the company reported year-on-year declines in net sales, ordinary profit, and quarterly net profit for the 9-month period ended in the third quarter. - FY2023-Q2Higher revenue, lower operating profit and higher ordinary profitAnnual report
「As a result, despite adverse economic conditions, the 6-month period ended in the second quarter saw higher net sales and ordinary profit overall: net sales were ¥1,281.833 million, up 0.5% year on year; operating profit was ¥333.264 million, down 7.6%; ordinary profit was ¥421.936 million, up 14.2%; and quarterly net profit was ¥292.686 million, up 17.4%.」
For the 6-month period ended in the second quarter, net sales increased slightly and ordinary profit and quarterly net profit rose, while operating profit declined year on year. - FY2023-Q1AdvancedAnnual report
「As a result of linking these activities to sales of its core product, the electronic medical record integration system “Hi Dental Spirit XR-10i,” net sales for the 3-month period ended in the first quarter were ¥687.752 million, up 33.3% year on year; operating profit was ¥183.294 million, up 140.0%; ordinary profit was ¥185.809 million, up 142.2%; and quarterly net profit was ¥124.691 million, up 160.0%.」
The company shifted from the previous fiscal year's full-year declines in net sales and profits and lower operating margin, with net sales, operating profit, ordinary profit, and quarterly net profit all increasing significantly year on year for the 3-month period ended in the first quarter. - FY2022Full-year declines in net sales and profits and deterioration in target indicatorsAnnual report
「The operating margin on net sales for the fiscal year was 18.8%, down from 25.4% in the previous fiscal year. The number of customers at the end of the fiscal year was 3,118, a decrease of 24 from the end of the previous fiscal year.」
Regarding the operating margin and customer numbers it considers important, the operating margin declined from 25.4% to 18.8%, while customer numbers fell from 3,142 to 3,118. - FY2022-Q3Lower net sales and profits for the cumulative quarterAnnual report
「The company promoted its business philosophy, “No sales without support; our customers' smiles and satisfaction are our joy; seeing their faces and connecting with their hearts,” and, under the motto “Support that is familiar, loved, and trusted,” linked these activities to sales of its core product, the electronic medical record integration system “Hi Dental Spirit XR-10i.” As a result, net sales for the 9-month period ended in the third quarter were ¥1,688.735 million, down 4.6% year on year; operating profit was ¥352.834 million, down 24.1%; ordinary profit was ¥381.086 million, down 11.7%; and quarterly net profit was ¥254.500 million, down 11.5%.」
While continuing sales activities for its core product, the company reported year-on-year declines in net sales, operating profit, ordinary profit, and quarterly net profit for the 9-month period ended in the third quarter. - FY2022-Q2AdvancedAnnual report
「As a result of linking these activities to sales of its core product, the electronic medical record integration system “Hi Dental Spirit XR-10i,” net sales for the 6-month period ended in the second quarter were ¥1,275.511 million, up 10.2% year on year; operating profit was ¥360.735 million, up 8.7%; ordinary profit was ¥369.469 million, up 23.9%; and quarterly net profit was ¥249.208 million, up 23.1%.」
The company shifted from reporting lower net sales and profits in the previous quarter to reporting year-on-year increases in net sales, operating profit, ordinary profit, and quarterly net profit as a result of sales activities for its core product. - FY2022-Q1Quarterly Results: Declines in Revenue and ProfitAnnual report
「As a result of these activities, net sales for the 3-month period ended in the first quarter were ¥515.995 million, down 0.9% year on year; operating profit was ¥76.378 million, down 41.4%; ordinary profit was ¥76.728 million, down 19.8%; and quarterly net profit was ¥47.960 million, down 25.4%.」
Although there was no change in the policy of emphasizing operating profit and customer numbers, the company reported year-on-year declines in net sales, operating profit, ordinary profit, and quarterly net profit for the 3-month period ended in the first quarter. - FY2021AdvancedAnnual report
「The operating margin on net sales for the fiscal year was 25.4%, up from 20.1% in the previous fiscal year. The number of customers at the end of the fiscal year was 3,142, an increase of 8 from the end of the previous fiscal year.」
Regarding the operating margin and customer numbers it considers important, the company reported annual results of a 25.4% operating margin and 3,142 customers. - FY2021-Q3AdvancedAnnual report
「As a result of linking these activities to sales of its core product, the electronic medical record integration system “Hi Dental Spirit XR-10i,” net sales for the 9-month period ended in the third quarter were ¥1,769 million, up 21.1% year on year; operating profit was ¥464 million, up 28.2%; ordinary profit was ¥431 million, up 15.0%; and quarterly net profit was ¥287 million, up 19.9%.」
The company reported increases in net sales, operating profit, and other items for the 9-month period ended in the third quarter as a result of activities linked to sales of its core product. - FY2020First statedAnnual report
「In seeking to enhance corporate value, the company places importance on profitability and industry market share.」
The company uses the operating margin as an indicator of profitability and customer numbers as an indicator of industry market share.